The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects host-cells via ACE2-receptors, which leads to pneumonia (COVID-19) but also can lead to myocarditis (acute myocardial injury) and chronic damage to the cardiovascular system. Therefore, cardiovascular protection may be necessary when treating patients with COVID-19 infection. This may especially be necessary in patients with cardiovascular diseases, risk factors, and co-medication.
Diagnostic Test: Assessment of cardiovascular diseases and cardiovascular risk factors
At inclusion, patients will be screened for pre-existing cardiovascular diseases and cardiovascular risk factors, as well as medication.
Inclusion Criteria:
- Patients with suspected SARS-CoV2/Covid-19 infection
Exclusion Criteria:
- Unwillingness to participate
University Hospital Essen
Essen, NRW, Germany
Tienush Rassaf, MD, Principal Investigator
University Hospital Essen, Deparment of Cardiology and Vascular Medicine